Biotech startups: opportunities, processes and funding
Biotech segments, the lab-to-market journey, regulatory approvals, infrastructure needs, funding, partnerships and business models.
By Editorial Team
Biotech uses living systems and biological processes to develop new products for health, agriculture, food and industry. With its scientific depth and long timelines, it is a major part of deep tech.
Segments
- Health biotech: diagnostics, biomarkers, drug and vaccine development, cell and gene therapies
- Agricultural biotech: breeding, biological fertilisers and crop protection; see our agritech guide
- Industrial biotech: enzymes, bio-based materials, fermentation-based production
- Food biotech: fermentation and new protein sources; see our foodtech guide
- Bioinformatics: analysing biological data with software and AI
From lab to market
- Basic research and proof of concept
- Product development and lab validation
- Scale-up and process development
- Regulatory filings and, where needed, clinical studies
- Commercialisation and distribution
Each stage needs its own capital and expertise. Match milestones to funding rounds; see our funding rounds guide.
Regulatory approvals
Health products, medical devices, drugs, food and agricultural products follow separate regulatory paths. Determine your category and required approvals early; see our health tech guide.
Infrastructure
Labs and equipment are expensive. University labs, technoparks, shared facilities and contract research organisations reduce early costs.
Funding
- R&D grants and international research programmes
- Biotech and health-focused funds
- Partnerships and milestone-based licensing deals with pharma, agri and chemical companies
- Public funds and programmes
Business models
- Licensing technology to a large company
- Co-development and revenue sharing
- Making and selling your own product
- A platform technology producing multiple products
Intellectual property
Patents are the basis of value in biotech. Protect inventions before publishing; see our IP guide.
Conclusion
Biotech is a long game with high impact potential. Pairing the science team with regulatory and commercial experience is key. Browse biotech startups on our sector page.
This guide is for general information only and is not legal, financial or investment advice. Check official sources and consult professionals for current terms.
